Friday, December 8, 2017


Compounding Exec Pleads Guilty Amid FDA Concern With Outsourcers
In recent months three compounding executives have been criminally charged after producing harmful medicines, including morphine for infants that was over 2,000 percent more potent than labeled, and FDA's top lawyer said Wednesday (Dec. 6) that the agency is dedicating significant resources to ...

No comments: